Table 2. The expression status of immune biomarkers.
| Immune biomarkers expression status | N (%) |
|---|---|
| Expression on TILs | |
| PD-1 | |
| Positive | 60 (43.2) |
| Negative | 79 (56.8) |
| LAG-3 | |
| Positive | 36 (25.9) |
| Negative | 103 (74.1) |
| TILs | |
| Positive | 76 (54.7) |
| Negative | 63 (45.3) |
| OX40 | |
| Positive | 71 (51.0) |
| Negative | 68 (49.0) |
| OX40L | |
| Positive | 102 (73.4) |
| Negative | 37 (26.6) |
| TIM3 | |
| Positive | 18 (12.9) |
| Negative | 121 (87.1) |
| GAL-9 | |
| Positive | 9 (6.5) |
| Negative | 130 (93.5) |
| PD-L1 | |
| Positive | 50 (36) |
| Negative | 89 (64) |
| MHCII | |
| Positive | 55 (39.6) |
| Negative | 84 (60.4) |
| Expression on tumors | |
| OX40 | |
| Positive | 14 (10.1) |
| Negative | 125 (89.9) |
| OX40L | |
| Positive | 36 (25.9) |
| Negative | 103 (74.1) |
| TIM3 | |
| Positive | 2 (1.4) |
| Negative | 137 (98.6) |
| GAL-9 | |
| Positive | 55 (39.6) |
| Negative | 84 (60.4) |
| PD-L1 | |
| Positive | 25 (18.0) |
| Negative | 114 (82.0) |
| MHCII | |
| Positive | 42 (30.2) |
| Negative | 97 (69.8) |